acetylcysteine has been researched along with losartan potassium in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KH; Kim, JH; Kim, KS | 1 |
| Alexander, S; Bärtsch, P; Dröge, W; Hildebrandt, W | 1 |
| Freudenthaler, SM; Gleiter, CH; Pilz, J; Schreeb, KH; Wiese, A | 1 |
| Iiyama, M; Kakihana, K; Kurosu, T; Miura, O | 1 |
| Arimitsu, N; Ito, T; Nagata, M; Sekimizu, K | 1 |
| Labban, B; Radhakrishnan, J | 1 |
| Slowinska-Lisowska, M; Szygula, Z; Szyszka, K; Witkowski, K; Zembron-Lacny, A | 1 |
| Cilio, MR; Ferriero, DM | 1 |
| Slowinska-Lisowska, M; Szygula, Z; Szyszka, K; Witkowski, Z; Zembron-Lacny, A | 1 |
| Chiang, CK; Chien, CT; Hsu, SP; Yang, SY | 1 |
| De Kock, M; Devuyst, O; Liistro, G; Momeni, M | 1 |
| Boesch-Saadatmandi, C; Ciesla, M; Dulak, J; Jozkowicz, A; Kozakowska, M; Loboda, A; Rimbach, G; Stachurska, A; Wolffram, S | 1 |
| Ferriero, DM; Juul, SE | 1 |
| Atar, S; Eizenberg, S; Feldman-Idov, Y; Kristal, B; Marzuq, N; Ofir, P; Shema-Didi, L; Sussan, M | 1 |
| Askenazi, D; Cerda, J; de Caestecker, M; Faubel, S; Fissell, WH; Harrell, FE; Humphreys, BD; Liu, KD; Mour, G; Nolin, TD; Okusa, MD; Pullen, N | 1 |
| Hong, L; Huang, Z; Li, H; Miao, B; Na, N; Zhang, J; Zhao, D | 1 |
| Cheung, PY; Schmölzer, GM; Solevåg, AL | 1 |
| Elshiekh, M; Kadkhodaee, M; Ranjbaran, M; Seifi, B | 1 |
| Aceti, A; Austin, T; Corvaglia, L; Faldella, G; Martini, S | 1 |
| Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M | 1 |
6 review(s) available for acetylcysteine and losartan potassium
| Article | Year |
|---|---|
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythropoietin; Fructose; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Melatonin; Neuroprotective Agents; Piracetam; Topiramate; Xenon | 2010 |
Pharmacologic neuroprotective strategies in neonatal brain injury.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Ascorbic Acid; Biopterins; Erythropoietin; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Fructose; Humans; Hypoxia-Ischemia, Brain; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Melatonin; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Topiramate; Vitamin E; Xenon | 2014 |
Bridging Translation by Improving Preclinical Study Design in AKI.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Erythropoietin; Free Radical Scavengers; Humans; Research Design; Sodium Bicarbonate; Translational Research, Biomedical | 2015 |
Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia.
Topics: Acetylcysteine; Allopurinol; Argon; Asphyxia Neonatorum; Cannabinoids; Erythropoietin; Female; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Magnesium Sulfate; Melatonin; Neuroprotective Agents; Oxidative Stress; Pregnancy; Treatment Outcome; Xenon | 2019 |
Free radicals and neonatal encephalopathy: mechanisms of injury, biomarkers, and antioxidant treatment perspectives.
Topics: Acetylcysteine; Allopurinol; Animals; Antioxidants; Asphyxia Neonatorum; Biomarkers; Brain Injuries; Clinical Trials as Topic; DNA; Erythropoietin; Free Radicals; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Malondialdehyde; Melatonin; Nitric Oxide; Oxidative Stress; Prostaglandins; Proteins; Uric Acid | 2020 |
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Ceftriaxone; Dibenzazepines; Drug Repositioning; Epilepsy; Epilepsy, Post-Traumatic; Erythropoietin; Fingolimod Hydrochloride; GABA Agents; Gabapentin; Humans; Immunologic Factors; Inflammation; Interleukin 1 Receptor Antagonist Protein; Isoflurane; Levetiracetam; Losartan; Neuroprotective Agents; Oxidative Stress; Pregabalin; Pyrrolidinones; Sirolimus; Stroke; Topiramate; Translational Research, Biomedical; Vigabatrin | 2020 |
7 trial(s) available for acetylcysteine and losartan potassium
| Article | Year |
|---|---|
Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity.
Topics: Acetylcysteine; Adult; Erythropoietin; Humans; Hypoxia; Male; Oxidation-Reduction; Oxygen; Pulmonary Ventilation; Respiration; Sulfhydryl Compounds; Time Factors | 2002 |
Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans.
Topics: Acetylcysteine; Adult; Antioxidants; Area Under Curve; Erythropoietin; Free Radical Scavengers; Humans; Hypoxia; Male; Malondialdehyde; Thioctic Acid | 2002 |
The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Antioxidants; Biomarkers; Cross-Over Studies; Double-Blind Method; Erythrocyte Indices; Erythrocytes; Erythropoietin; Exercise; Glutathione; Hematocrit; Hemoglobins; Humans; Lipid Peroxidation; Male; Protein Carbonylation; Thiobarbituric Acid Reactive Substances; Thioctic Acid; Time Factors; Young Adult | 2009 |
Modulatory effect of N-acetylcysteine on pro-antioxidant status and haematological response in healthy men.
Topics: Acetylcysteine; Antioxidants; Erythrocytes; Erythropoietin; Exercise; Free Radical Scavengers; Glutathione; Glutathione Peroxidase; Hematologic Tests; Humans; Lipid Peroxidation; Male; Young Adult | 2010 |
N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antioxidants; Case-Control Studies; Chlorides; Dinoprost; Erythropoietin; Female; Ferric Compounds; Hematocrit; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis | 2010 |
Effect of N-acetyl-cysteine and hyperoxia on erythropoietin production.
Topics: Acetylcysteine; Adult; Erythropoietin; Exercise Test; Female; Humans; Hyperoxia; Male; Middle Aged; Oxygen; Oxygen Consumption; Respiratory Function Tests; Time Factors; Young Adult | 2011 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary Angiography; Cystatin C; Cytoprotection; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Humans; Infusions, Intravenous; Iohexol; Israel; Lipocalin-2; Male; Middle Aged; Prospective Studies; Protective Agents; Recombinant Proteins; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2016 |
7 other study(ies) available for acetylcysteine and losartan potassium
| Article | Year |
|---|---|
N-acetylcysteine increases the biosynthesis of recombinant EPO in apoptotic Chinese hamster ovary cells.
Topics: Acetylcysteine; Animals; Apoptosis; Butyrates; Cell Division; Cell Membrane; Cell Size; Cell Survival; CHO Cells; Cricetinae; DNA Fragmentation; Drug Synergism; Erythropoietin; Recombinant Proteins; Time Factors; Vacuoles | 1999 |
Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Cycle; Cell Cycle Proteins; Cell Line; Erythropoietin; Hematopoietic Stem Cells; Interleukin-3; Mice; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Receptors, Erythropoietin; Receptors, Interleukin-3; Signal Transduction | 2006 |
Antioxidant N-acetyl-L-cysteine inhibits erythropoietin-induced differentiation of erythroid progenitors derived from mouse fetal liver.
Topics: Acetylcysteine; Animals; Antigens, Differentiation; Blood Group Antigens; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; GATA1 Transcription Factor; Liver; MafK Transcription Factor; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
The case/Renal failure after percutaneous closure of a perivalvular leak.
Topics: Acetylcysteine; Aged; Aortic Valve; Aortic Valve Insufficiency; Aspartate Aminotransferases; Bilirubin; Cardiac Catheterization; Drug Administration Schedule; Erythropoietin; Ferrous Compounds; Folic Acid; Glucose; Heart Valve Prosthesis; Hematinics; Hemoglobinuria; Hemolysis; Humans; Infusions, Intravenous; L-Lactate Dehydrogenase; Male; Mitral Valve; Mitral Valve Insufficiency; Renal Insufficiency; Treatment Outcome; Ultrasonography | 2008 |
Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Deferoxamine; Epithelial Cells; Erythropoietin; Gene Expression Regulation; Heme Oxygenase-1; Kidney Tubules, Proximal; MicroRNAs; NF-E2-Related Factor 2; Ochratoxins; Reactive Oxygen Species; Signal Transduction; Swine; Transforming Growth Factor beta | 2013 |
Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation.
Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Erythropoietin; Gene Expression Regulation; Humans; Imidazoles; Interferon-gamma; Kidney; Kidney Transplantation; Lentivirus; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Pyrimidines; Rats; Reperfusion Injury; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor | 2018 |
Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
Topics: Acetylcysteine; Animals; Blood Urea Nitrogen; Creatinine; Cytokines; Disease Models, Animal; Erythropoietin; Ischemic Preconditioning; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury | 2019 |